{"id":768289,"date":"2023-07-07T07:03:38","date_gmt":"2023-07-07T11:03:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/"},"modified":"2023-07-07T07:03:38","modified_gmt":"2023-07-07T11:03:38","slug":"beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/","title":{"rendered":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023<\/b><\/p>\n<p>BASEL, Switzerland &amp; BEIJING &amp; CAMBRIDGE, Mass&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nBeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company,<b \/>today announced that the Company will host an investor Research and Development Day in New York City and via webcast on July 18, 2023. John V. Oyler, BeiGene&#8217;s Co-Founder, Chairman and CEO, along with the Company&#8217;s leadership team, will provide an update on BeiGene\u2019s deep and broad global innovation pipeline and platforms, and share insights on the Company&#8217;s vision, differentiated capabilities, and value creation drivers.<\/p>\n<p>\nLive webcast of this event can be accessed from the investors section of BeiGene\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fir.beigene.com&amp;esheet=53441350&amp;newsitemid=20230707825257&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.beigene.com&amp;index=1&amp;md5=89162c5139853bf847e9896e3d441226\">http:\/\/ir.beigene.com<\/a> , <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fhkexir.beigene.com&amp;esheet=53441350&amp;newsitemid=20230707825257&amp;lan=en-US&amp;anchor=http%3A%2F%2Fhkexir.beigene.com&amp;index=2&amp;md5=60aefa8838d6378f9d4e8e1a33b17541\">http:\/\/hkexir.beigene.com<\/a> or <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsseir.beigene.com&amp;esheet=53441350&amp;newsitemid=20230707825257&amp;lan=en-US&amp;anchor=https%3A%2F%2Fsseir.beigene.com&amp;index=3&amp;md5=deea6e8b8643e27e99eecc4ea807942b\">https:\/\/sseir.beigene.com<\/a>. Archived replays will be available for 90 days following the event.<\/p>\n<p><b>About BeiGene<\/b><\/p>\n<p>\nBeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,400 colleagues spans five continents, with administrative offices in Basel; Beijing; and Cambridge, U.S. To learn more about BeiGene, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.beigene.com&amp;esheet=53441350&amp;newsitemid=20230707825257&amp;lan=en-US&amp;anchor=www.beigene.com&amp;index=4&amp;md5=2000c636af6c53f749451dd3e503bdd0\">www.beigene.com<\/a> and follow us on Twitter at @BeiGeneGlobal.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene&#8217;s plans, commitments, aspirations and goals related to BeiGene\u2019s medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled \u201cRisk Factors\u201d in BeiGene\u2019s most recent quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) as well as discussions of potential risks, uncertainties, and other important factors in BeiGene&#8217;s subsequent filings with the SEC. All information in this presentation is as of the date presented, and BeiGene undertakes no duty to update such information unless required by law.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20230707825257\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20230707825257\/en\/<\/a><\/span><\/p>\n<p><b>Investors:<br \/>\n<\/b><br \/>Liza Heapes<br \/>\n<br \/>+1 857-302-5663<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@beigene.com\">ir@beigene.com<\/a><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/>Kyle Blankenship<br \/>\n<br \/>+1 667-351-5176<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:media@beigene.com\">media@beigene.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York Massachusetts Switzerland China United States North America Asia Pacific Europe<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Oncology Health Other Science Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230707825257\/en\/1612468\/3\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 BASEL, Switzerland &amp; BEIJING &amp; CAMBRIDGE, Mass&#8211;(BUSINESS WIRE)&#8211; BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company,today announced that the Company will host an investor Research and Development Day in New York City and via webcast on July 18, 2023. John V. Oyler, BeiGene&#8217;s Co-Founder, Chairman and CEO, along with the Company&#8217;s leadership team, will provide an update on BeiGene\u2019s deep and broad global innovation pipeline and platforms, and share insights on the Company&#8217;s vision, differentiated capabilities, and value creation drivers. Live webcast of this event can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com , http:\/\/hkexir.beigene.com or &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-768289","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 BASEL, Switzerland &amp; BEIJING &amp; CAMBRIDGE, Mass&#8211;(BUSINESS WIRE)&#8211; BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company,today announced that the Company will host an investor Research and Development Day in New York City and via webcast on July 18, 2023. John V. Oyler, BeiGene&#8217;s Co-Founder, Chairman and CEO, along with the Company&#8217;s leadership team, will provide an update on BeiGene\u2019s deep and broad global innovation pipeline and platforms, and share insights on the Company&#8217;s vision, differentiated capabilities, and value creation drivers. Live webcast of this event can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com , http:\/\/hkexir.beigene.com or &hellip; Continue reading &quot;BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-07T11:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023\",\"datePublished\":\"2023-07-07T11:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/\"},\"wordCount\":440,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/\",\"name\":\"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2023-07-07T11:03:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/","og_locale":"en_US","og_type":"article","og_title":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk","og_description":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 BASEL, Switzerland &amp; BEIJING &amp; CAMBRIDGE, Mass&#8211;(BUSINESS WIRE)&#8211; BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company,today announced that the Company will host an investor Research and Development Day in New York City and via webcast on July 18, 2023. John V. Oyler, BeiGene&#8217;s Co-Founder, Chairman and CEO, along with the Company&#8217;s leadership team, will provide an update on BeiGene\u2019s deep and broad global innovation pipeline and platforms, and share insights on the Company&#8217;s vision, differentiated capabilities, and value creation drivers. Live webcast of this event can be accessed from the investors section of BeiGene\u2019s website at http:\/\/ir.beigene.com , http:\/\/hkexir.beigene.com or &hellip; Continue reading \"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-07T11:03:38+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023","datePublished":"2023-07-07T11:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/"},"wordCount":440,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/","name":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2023-07-07T11:03:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20230707825257r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/beigene-to-host-investor-research-and-development-day-in-person-and-via-webcast-on-july-18-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BeiGene to Host Investor Research and Development Day in Person and via Webcast on July 18, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=768289"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/768289\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=768289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=768289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=768289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}